These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2438320

  • 1. Effects of N-acetylprocainamide on experimental atrial flutter and atrial electrophysiologic properties in conscious dogs with sterile pericarditis: comparison with the effects of quinidine.
    Okumura K, Waldo AL.
    J Am Coll Cardiol; 1987 Jun; 9(6):1332-8. PubMed ID: 2438320
    [Abstract] [Full Text] [Related]

  • 2. Effects of N-acetylprocainamide and recainam in the pharmacologic conversion and suppression of experimental canine atrial flutter: significance of changes in refractoriness and conduction.
    Feld GK, Venkatesh N, Singh BN.
    J Cardiovasc Pharmacol; 1988 May; 11(5):573-80. PubMed ID: 2455844
    [Abstract] [Full Text] [Related]

  • 3. Effect of procainamide and N-acetylprocainamide on atrial flutter: studies in vivo and in vitro.
    Wu KM, Hoffman BF.
    Circulation; 1987 Dec; 76(6):1397-408. PubMed ID: 2445503
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
    Feld GK, Venkatesh N, Singh BN.
    Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of interruption of atrial flutter by moricizine. Electrophysiological and multiplexing studies in the canine sterile pericarditis model of atrial flutter.
    Ortiz J, Nozaki A, Shimizu A, Khrestian C, Rudy Y, Waldo AL.
    Circulation; 1994 Jun; 89(6):2860-9. PubMed ID: 8205702
    [Abstract] [Full Text] [Related]

  • 6. Electrophysiologic effects of a new class III antiarrhythmic agent, E-4031, on atrial flutter, atrial refractoriness, and conduction delay in a canine sterile pericarditis model.
    Shimizu A, Kaibara M, Centurion OA, Kapuku G, Hirata T, Fukatani M, Yano K, Hashiba K.
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):656-62. PubMed ID: 7681913
    [Abstract] [Full Text] [Related]

  • 7. Circus movement atrial flutter in the canine sterile pericarditis model. Differential effects of procainamide on the components of the reentrant pathway.
    Schoels W, Yang H, Gough WB, el-Sherif N.
    Circ Res; 1991 Apr; 68(4):1117-26. PubMed ID: 2009611
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis.
    Pagé PL, Hassanalizadeh H, Cardinal R.
    Can J Physiol Pharmacol; 1991 Jan; 69(1):15-24. PubMed ID: 2036596
    [Abstract] [Full Text] [Related]

  • 10. Oral N-acetylprocainamide compared to quinidine plus digoxin in the chronic suppression of atrial flutter in humans.
    Feld GK, Nademanee K, Noll E, Singh BN.
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):191-8. PubMed ID: 2484856
    [Abstract] [Full Text] [Related]

  • 11. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
    Sung RJ, Juma Z, Saksena S.
    Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
    [Abstract] [Full Text] [Related]

  • 12. Termination of Atrial Flutter and Fibrillation by K201's Metabolite M-II: Studies in the Canine Sterile Pericarditis Model.
    Sadrpour SA, Serhal M, Khrestian CM, Lee S, Fields T, Dittrich HC, Waldo AL.
    J Cardiovasc Pharmacol; 2015 May; 65(5):494-9. PubMed ID: 25636078
    [Abstract] [Full Text] [Related]

  • 13. Circus movement atrial flutter in canine sterile pericarditis model. Activation patterns during entrainment and termination of single-loop reentry in vivo.
    Schoels W, Restivo M, Caref EB, Gough WB, el-Sherif N.
    Circulation; 1991 May; 83(5):1716-30. PubMed ID: 2022026
    [Abstract] [Full Text] [Related]

  • 14. Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap.
    Inoue H, Yamashita T, Nozaki A, Sugimoto T.
    J Am Coll Cardiol; 1991 Oct; 18(4):1098-104. PubMed ID: 1910060
    [Abstract] [Full Text] [Related]

  • 15. Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model.
    Buchanan LV, LeMay RJ, Walters RR, Hsu CY, Brunden MN, Gibson JK.
    J Cardiovasc Electrophysiol; 1996 Feb; 7(2):113-9. PubMed ID: 8853021
    [Abstract] [Full Text] [Related]

  • 16. Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy.
    Cha Y, Wales A, Wolf P, Shahrokni S, Sawhney N, Feld GK.
    J Cardiovasc Electrophysiol; 1996 Sep; 7(9):809-27. PubMed ID: 8884510
    [Abstract] [Full Text] [Related]

  • 17. Atrial activation sequence during atrial flutter in the canine pericarditis model and its effects on the polarity of the flutter wave in the electrocardiogram.
    Okumura K, Plumb VJ, Pagé PL, Waldo AL.
    J Am Coll Cardiol; 1991 Feb; 17(2):509-18. PubMed ID: 1991911
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of spontaneous termination of stable atrial flutter in the canine sterile pericarditis model.
    Ortiz J, Igarashi M, Gonzalez HX, Laurita K, Rudy Y, Waldo AL.
    Circulation; 1993 Oct; 88(4 Pt 1):1866-77. PubMed ID: 8403332
    [Abstract] [Full Text] [Related]

  • 19. Activation patterns in experimental canine atrial flutter produced by right atrial crush injury.
    Feld GK, Shahandeh-Rad F.
    J Am Coll Cardiol; 1992 Aug; 20(2):441-51. PubMed ID: 1634684
    [Abstract] [Full Text] [Related]

  • 20. Arrhythmia control by selective lengthening of cardiac repolarization: role of N-acetylprocainamide, active metabolite of procainamide.
    Singh BN, Feld G, Nademanee K.
    Angiology; 1986 Dec; 37(12 Pt 2):930-8. PubMed ID: 2433967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.